About Optogenetics
Optogenetic is the biological technique in which light is used to control the cell in living tissue, it is emerging technique. The optogenetics helps to understand the normal and abnormal functioning of brain and used to treat the neurological disorder. In Optogenetics light and genetic engineering is used to control the cell activity and neurons activity. Optogenetics is used to treat the retinal disease, hearing loss, memory disorder. Optogenetics is a stimulation technique that relies on the expression of light-sensitive proteins in the neuronal cell membrane. Optogenetics aids in the facilitation of a wide variety of studies aimed at better understanding neuronal pathways in normal and abnormal conduct. It enables researchers to investigate how the neurological activity patterns within individual brain cells give rise to emotions, actions, and memories at a previously unattainable level of precision.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Unit | Value (USD Million) |
CAGR | 16.3% |
Market players are focusing on providing optogenetics with higher quality along with complying all regulatory standards to fascinate more end users. They are also focusing on the introduction of numerous advanced & attractive features to further offer qualified treatment. The market is concentrated with the presence of several international market leaders and research laboratories. The high focus on the offering cost effective product offerings. Besides, the numerous industry profitability has led the entry of new players, in turn, increasing the level of rivalry in the already competitive market. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Optogenetics market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Coherent, Inc. (United States), Thorlabs, Inc. (United States), Cobalt International Energy, Inc. (United States), Scientifica (United Kingdom), Laserglow Technologies (Canada), Gensight Biologics (France), Jackson Laboratories (United States), Regenxbio Inc.(United States), Addgene(United States) and Bruker (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Circuit Therapeutics, Inc.(United States) and Penn Vector Core(United States).
Segmentation Overview
AMA Research has segmented the market of Global Optogenetics market by , Application (Retinal disease treatment, Neuroscience, Cardioversion, Pacing and Others) and Region.
On the basis of geography, the market of Optogenetics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Actuators, the sub-segment i.e. Halorhodospin will boost the Optogenetics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Sensor Type, the sub-segment i.e. Genetically Modified Calcium Indicators will boost the Optogenetics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Equipment Type, the sub-segment i.e. Laser will boost the Optogenetics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Increasing Use of Multimodal Imaging
Market Growth Drivers:
Rise in Prevalence Of Neuronal Disorders Such As, Epilepsy, Brain Tumorsand Parkinson's, Increasing Awareness about Neurological Diseases and Availability of Genetic Reagents
Challenges:
Lack of Awareness in Underdeveloped and Developing Regions
Restraints:
High Cost of Technology
Opportunities:
Rapid Growth of Advanced Technology, Aids in the Facilitation of a Wide Variety of Studies Aimed At Better Understanding Neuronal Pathways in Normal and Abnormal Conduct and Augmented Support from the Government
Market Leaders and their expansionary development strategies
In September 2021, Novartis thas acquired Arctos Medical. It has programmed pre-clinical optogenetics-based AAV gene therapy and Arctos’ proprietary technology to its ophthalmology portfolio. With this acquisition, Novartis has led to the successful commitment to finding treatments for patients with vision loss and the potential of optogenetics as the basis of successful therapeutics.
Any optogenetic therapy in the brain almost certainly require both a viral vector and an implantable medical device. The viral vector would classify as a Gene Therapy Medicinal Product (GTMP), falling within the Advanced Therapy Medicinal Product (ATMP) regulatory framework.19 Meanwhile, the device would class as an active implantable medical device (AIMD) within the Medical Device Regulations (MDR).20. As per EU, the combined advanced therapy medical product is classified and it must incorporate, as an integral part of the product, one or more medical devices.
Key Target Audience
Biotechnology Companies, R & D Laboratories, Suppliers and Distributors of the Medical Devices, End-User and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.